Published February 2002
| Version v1
Journal article
FDG-PET in gynecologic cancer
Description
Whole-body positron emission tomography (PET) imaging with 18-F deoxyglucose (FDG) is a molecular imaging modality that detects metabolic alternation in tumor cells. In various human cancers, FDG-PET shows a potential clinical benefit in screening, tumor characterization, staging, therapeutic follow-up and detecting recurrence. In gynecologic cancers, FDG-PET is also known to be effective in characterization of adnexal masses, detection of recurrence, and lymph node invasion. This review discusses the clinical feasibility and future clinical application of this imaging modality in patients with cervical cancer, ovarian cancer and other gynecologic cancers
Additional details
Publishing Information
- Journal Title
- Korean Journal of Nuclear Medicine
- Journal Volume
- 36
- Journal Issue
- 1
- Series
- 23 refs, 2 figs, 3 tabs
- Journal Page Range
- p. 46-52
- ISSN
- 1225-6714
INIS
- Country of Publication
- Korea, Republic of
- Country of Input or Organization
- Korea, Republic of
- INIS RN
- 33059174
- Subject category
- S62: RADIOLOGY AND NUCLEAR MEDICINE;
- Descriptors DEI
- FLUORINE 18; GYNECOLOGY; IMAGES; LYMPH NODES; NEOPLASMS; OVARIES; PATIENTS; POSITRON COMPUTED TOMOGRAPHY; THERAPEUTIC USES; TUMOR CELLS
- Descriptors DEC
- ANIMAL CELLS; BETA DECAY RADIOISOTOPES; BETA-PLUS DECAY RADIOISOTOPES; BODY; COMPUTERIZED TOMOGRAPHY; DIAGNOSTIC TECHNIQUES; DISEASES; EMISSION COMPUTED TOMOGRAPHY; FEMALE GENITALS; FLUORINE ISOTOPES; GONADS; HOURS LIVING RADIOISOTOPES; ISOMERIC TRANSITION ISOTOPES; ISOTOPES; LIGHT NUCLEI; LYMPHATIC SYSTEM; MEDICINE; NANOSEC LIVING RADIOISOTOPES; NUCLEI; ODD-ODD NUCLEI; ORGANS; RADIOISOTOPES; TOMOGRAPHY; USES